Search by keywords: Connect with us Sloan Kettering @GSKGradSchool 521 News Items found Exploring the ‘Forgotten Genome’ and More: At Work with Molecular Biologist Agnel Sfeir Thursday, March 18, 2021 Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021. Feature In Memoriam: Developmental Biologist Kathryn V. Anderson Monday, March 1, 2021 Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute. To Improve Immunotherapy, Researchers Look to Shift Immune Cells’ Access to Sugar Monday, February 15, 2021 More sugar available for immune cells could mean better immune responses against cancer. Finding MSK Researchers Learn What’s Driving ‘Brain Fog’ in People with COVID-19 Monday, February 8, 2021 The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19. Tree-Derived Cancer Drug Shows Promise in Treating COVID-19 Virus Monday, February 8, 2021 Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties. In the Lab Research Shows How Common Feature of Blood Cancers Can Be Targeted Friday, February 5, 2021 Research points to the role of a protein called MYB, which has long been known to play a role in cancer. Sloan Kettering Institute Scientists Learn How Genes and Environment Conspire in Pancreatic Cancer Development Wednesday, February 3, 2021 The insights lay the groundwork for earlier diagnosis and better treatment of the disease. Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer Thursday, January 21, 2021 Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer. Confronting a Crisis: How MSK Cancer Geneticists Responded to COVID-19 Friday, January 8, 2021 During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists. Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach Monday, December 28, 2020 The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability. Pagination Load More